Key result
Systemic hyperkalemia and continuous perfusion without cross-clamping provides myocardial protection during MVR in porcelain aorta.
Why the study?
Redo cardiac surgery presents clinical challenges with high perioperative risk, particularly during mitral valve reoperations in patients with patent coronary grafts and calcified aorta where cross-clamping carries a high stroke risk.
Case Report (n=1)
Systemic hyperkalemia with continuous blood perfusion offers a viable myocardial protection strategy for mitral valve replacement in patients with a porcelain aorta and patent coronary grafts where cross-clamping carries a high risk of stroke.
May aid hyperkalemia management in redo mitral surgery; hypothesis-generating and requires prospective validation.
Redo cardiac surgery represents a clinical challenge due to a higher rate of perioperative morbidity and mortality.Mitral valve (MV) reoperations can particularly be demanding in patients with patent coronary grafts, previous aortic valve replacement, calcified aorta or complications following a previous operation.In this article we describe technique to manage systemic hyperkalemia in 68-year-old man who underwent bioprosthetic mitral valve replacement, already undergone coronary artery bypass grafting 13 years, come in our clinic to aggravated dyspnea caused by severe stenosis of the mitral valve.Because cross-clamping would have a high risk of stroke owing to severe calcification of the ascending aorta systemic hyperkalemia and continuous blood perfusion can guarantee adequate myocardial protection particularly in the case of patent grafts, decreasing potential lesions due to demanding clamp placing.
No takes yet. Share an insight, caveat, or question.
Giuseppe Speziale (2019) conducted a case report in Severe mitral valve stenosis with porcelain aorta and previous CABG (n=1). Systemic hyperkalemia and continuous blood perfusion without cross-clamping was evaluated. Systemic hyperkalemia and continuous blood perfusion without cross-clamping provided adequate myocardial protection during mitral valve replacement in a patient with a porcelain aorta and patent grafts.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: